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Abstract: This article focuses on the molecular modeling of the release of doxorubicin 
from capsules composed of glucosamine(ethylene glycol) oligomers. Doxorubicin forms 
micelle structures with glucosamine(ethylene glycol), and the drug release mechanism 
can be studied through the modeling of oligomeric bond breaking under acidic, neutral, 
or basic conditions. Under these conditions, the activation energies were calculated to be 
145.51, 135.78, and 287.60 kcal/mol, respectively, at the B3LYP/6-31G//PM3 level. 
Based on these values, doxorubicin can be released into acidic and neutral solutions but 
not into basic solution. Ethylene glycol chain length in glucosamine(ethylene glycol) also 
effects drug release. As the length of ethylene glycol increases, the amount of drug 
released increases under acidic conditions, but decreases under neutral and basic 
conditions. When the drug is released from glucosamine(ethylene glycol) oligomers, the 
drug molecule and glucosamine(ethylene glycol) molecules form a micelle structure. 
Studies found that, as the length of the ethylene glycol chains increases, the micelle 
structure is more easily formed. The ethylene glycol group can deliver doxorubicin to 
cancer cells in micelle form.     
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1. Introduction 
 
Doxorubicin is an anthracycline ring antibiotic that is widely used as a cancer therapeutic. Common 
treatment side effects include nausea and vomiting, loss of appetite, diarrhea, and swelling [1], but 
development of a system capable of selectively delivering the drug to the intended target cells may be 
able to reduce these complications.  
There are many approaches to drug delivery via drug/drug carrier combinations, such as 
encapsulation, hydrogel formation, nanoaggregation, and micellar delivery. For doxorubicin delivery, 
encapsulation and micellar delivery have received increased attention because this system can protect 
and carry the drug directed to its intended target. Brannon-Peppas and Blanchette [2] reported that 
tumor volumes in mice treated with an encapsulated drug conjugate were lower than tumor volumes in 
those treated with the conjugate alone. Janes et al. [3] modified chitosan nanoparticles to carry the 
doxorubicin. Wang et al. [4] encapsulated the chitosan, which has poor solubility in water, to increase 
the efficiency of drug delivery. Chan et al. [5] synthesized chitosan-g-poly(ethylene glycol) as an 
alternative drug delivery system with the intention that conjugation to poly(ethylene glycol) would 
increase the solubility of chitosan. There are several studies on micellar delivery of doxorubicin. 
Xiangyang et al. [6] used N-succinyl-N-octylchitosan micelles as doxorubicin carriers with effective 
anti-tumor activity. Zhang et al. [7] attached 10-hydroxycamptothecin, a hydrophobic anticancer drug, 
to amphiphilic N-alkyl-N-trimethylchitosan derivatives, resulting in increased drug solubility and 
controlled release. 
Drug carriers usually have some chemical functional group used to detect their cancer cell targets. 
Yang et al. [8] used isocyanate terminated linear polyethylene glycol to carry drugs to cancer cells. 
Doxorubicin can be effectively delivered via conjugation to chitosan nanoparticles [9]. Son et al. [10] 
studied the tumor-targeting properties of glycol-chitosan nanoaggregates in vivo using fluorescein 
isothiocyanate-conjugated glycol-chitosan nanoaggregates and doxorubicin-conjugated glycol-chitosan 
(GC-DOX). Okabe et al. [11] studied P-glycoprotein efflux transporters, which confer drug resistance 
by decreasing the intracellular accumulation of anticancer drugs. Based on these previous experiments, 
we concluded that doxorubicin can be conjugated to a biopolymer that selectively targets cancer cells.  
Quantum mechanical molecular simulation can be used to study drug delivery. Certain techniques, 
specifically semi-empirical and ab initio methods, are useful for simulating molecular interactions for 
drug delivery applications. Zavodinsky and Mikhailenko [12] simulated reactions between carbon 
nanoclusters and molecular oxygen using a semi-empirical PM3 method and found that reactivity 
depended on the structure of clusters and on the positions of the reactive carbon atoms. Propylene 
oxide structure optimization can be performed using semi-empiracal and ab initio methods [13]. The 
predicted bond lengths and bond angles agreed with experimental data. Simulations of the effect of 
hydrophobic molecules on aqueous solutions of amphiphilic block copolymers found that hydrophobic 
molecules will dissolve in micellar solutions [14]. This effect has also been investigated in detail by 
cryogenic transmission electron microscopy (TEM).  
Cummins and Gready [15] used semi-empirical AM1 and PM3 methods to describe molecular 
interactions. Their method was applied to calculate the free energy of the enzymatic reduction of 
dihydrofolate (DHF) with nicotinamide adenine dinucleotide phosphate (NADPH) via Escherichia coli 
dihydrofolate reductase. The free energy change of this reaction agreed with the experimental results. Int. J. Mol. Sci. 2008, 9  
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Ab initio methods have used density functional theory (DFT), which was suitable for simulating 
reactions [16, 17]. 
In this work, the drug delivery doxorubicin with bis-polymer (chitosan) was studied for potential 
applications as an anticancer therapeutic. Both semi-empirical and ab intio methods were applied to 
optimize the structures of the relevant molecules and to find the possible mechanism of   
micelle formation.     
   
2. Methodology 
  
The encapsulation of doxorubicin within glucosamine(ethylene glycol) oligomers was simulated, 
and this process involved three steps. The first step was the structural optimization of both doxorubicin 
and glucosamine(ethylene glycol) using semi-empirical AM1 and PM3 methods and ab initio HF/6-
31G methods. Optimization results show the potential of using glucosamine(ethylene glycol) as a drug 
delivery system.  The oligomers form H-bonds with doxorubicin, and arrange the position of ethylene 
glycol at the outter site of micelle molecule in order to detect the target cells. The process of assembly 
was broken down into two parts, encapsulation and micelle formation. The second step was to simulate 
the release of doxorubicin from glucosamine(ethylene glycol) by considering the hydrolysis of 
diglucosamine(ethylene glycol) under acidic, neutral, and basic conditions (Scheme1).  
 
Scheme 1. Hydrolysis of diglucosamine(ethylene glycol) under acidic, neutral, and basic 
conditions. 
 
 
The third step was to study micelle formation with doxorubicin following the hydrolysis of 
diglucosamine(ethylene glycol) using B3LYP/6-31G//PM3 methods to simulate H-bond interactions. 
These simulations are calculated in gas phase and constant temperature at 298 K. All simulations were 
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performed with Gaussian 03W and GaussView using computers equipped with Intel® Dual-Core 
Xeon™ 3.0 GHz  processors and 2.0 GB of RAM. Input files will be available on 
http://www.ku.ac.th/~chemeng. 
 
3. Results and Discussion 
 
3.1. Structural optimization of doxorubicin and glucosamine(ethylene glycol) 
 
Structures were optimized using molecular modeling methods. Frimand and Jalkanen [13] 
simulated propylene oxide with semi-empirical and ab initio methods, and their predictions were in 
good agreement with experimental data. Cummins and Gready [15] used semi-empirical quantum 
mechanical methods to describe molecular interactions relevant to the enzymatic cleavage of ribose 
ring phosphate groups from NADPH. The semi-empirical AM1 and PM3 predictions both agreed with 
experimental results.  
In this study, the semi-empirical PM3 method was used to optimize the molecular geometries of 
doxorubicin and glucosamine(ethylene glycol). Bond lengths and charge structure were both 
considered geometric parameters and were optimized in this fashion.  
 
 3.1.1. Doxorubicin 
 
The optimized doxorubicin structures obtained from semi-empirical AM1 and PM3 methods and 
from the ab initio HF/6-31G method were identical (Figure 1).  
 
Figure 1. Optimized structure of doxorubicin. 
 
Some geometric parameters corresponding to this optimal structure are given in Table 1.The HF 
method predicted a more optimal structure than either the AM1 or the PM3 methods, but all three 
predictions demonstrated the same basic trends. 
Benzene rings Int. J. Mol. Sci. 2008, 9  
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Table 1. Geometric parameters of optimized doxorubicin structure. 
   Semi-empirical  Ab initio 
Bond length  AM1  PM3  HF/6-31G 
C64 - H66  1.117  1.096  1.082 
C64 - O63  1.424  1.406  1.429 
C2   - O63  1.376  1.375  1.359 
C16 - O20  1.374  1.363  1.363 
C3   - C11  1.48  1.495  1.492 
C19 - C25  1.504  1.511  1.518 
C29 - C32  1.533  1.558  1.532 
C48 - N60  1.45  1.488  1.451 
O20 - H21  0.971  0.962  0.959 
N60 - H61  0.999  0.998  0.996 
C11 = O15  1.233  1.213  1.215 
C1 = C2  1.405  1.404  1.389 
Dihedral angle          
H65-C64-O63-C2 -65.1 -66.2  -66.2 
C2-C3-C11-O15 28.6  41.8  31.7 
C13-C17-O22-H23 -167 178.6  145.4 
C50-C48-N50-H61 -143.1 -162.3  -175.9 
O35-C32-C36-O39 131.4 106.6  126.5 
H9-C6-C5-H8 -0.4  0.3  0.1 
C5-C4-C10-O14 -20  -21.7  -9.8 
O28-C16-C18-C24 0.5  0.1  0.7 
C10-C4-C3-C11 -3.5 -6.6  -7.8 
 
3.1.2. Glucosamine(ethylene glycol) 
 
The optimal structure of glucosamine(ethylene glycol) was simulated using the same three 
aforementioned methods (AM1, PM3 and HF/6-31G).  All three methods yielded nearly identical 
structures (Figure 2). 
 
Figure 2. Optimized structure of glucosamine(ethylene glycol). 
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The relevant geometric structural parameters from each method are given in Table 2.  
Table 2. Geometrical parameters of optimized glucosamine(ethylene glycol) structure. 
   Semi-empirical  Ab initio 
Bond length  AM1  PM3  HF/6-31G 
C3 - H4  1.134  1.121  1.079 
C1 - C3  1.552  1.555  1.534 
C3 - C9  1.548  1.549  1.529 
C1 - O23  1.409  1.401  1.42 
C1 - O15  1.415  1.41  1.426 
C3 - N20  1.445  1.482  1.452 
N20 - H22  1.002  0.999  0.998 
O11 - H12  0.967  0.948  0.953 
Dihedral angle          
H21-N20-C3-1C 169.9  164.2  157.9 
O11-C9-C7-O13 -56.9  -63.7  -55.3 
C7-C5-C16-O19 -62.5  -73.1  -56.8 
O19-C25-C26-O27 175.8  175.4  -179.4 
C1-O15-C5-C16 93.9  89  104.4 
H22-H20-C3-4H 173.4  166.7  174.7 
H2-C1-15O-5C 175.6  166.7  174.2 
H6-5C-16C-19O 58.6 49.8  63.5 
H8-7C-5C-16C -30.1  -20.1  -39.8 
 
All three methods predicted the same optimum structure, so the AM1, PM3, and HF methods can 
all be used for structure optimization. The optimized molecular structures for glucosamine(ethylene 
glycol) and doxorubicin were then used to study the two molecules’ interactions. 
 
3.2. Drug release from capsules 
 
The release of doxorubicin from its oligoglucosamine(ethylene glycol) capsule requires breaking 
the oligmeric bonds of oligoglucosamine(ethylene glycol). The probability of reaction can be 
estimated from the difference in total molecular energies between the products and the reactants. 
Simulations revealed that the capsule’s polymer bonds can be broken under acidic, normal, or basic 
conditions.  These simulations involved two steps. First, molecular structures were optimized using the 
semi-empirical PM3 method. Second, the molecular energies were calculated via ab initio 
HF/B3LYP/6-31G method.  
 
3.2.1. Acidic conditions  
 
The following assumptions were made to simulate polymeric bond breaking under acidic 
conditions: (1) hydrolysis of diglucosamine(ethylene glycol) was used to represent cleavage of Int. J. Mol. Sci. 2008, 9  
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glucosamine(ethylene glycol) oligomers, and (2) H3O
+ (hydronium ion) was used to represent   
acidic conditions.  
The reaction was also assumed to have four continuous steps. First, the hydronium ion complexes 
with diglucosamine(ethylene glycol) at the polymeric bond. Second, the hydrogen atom of the 
hydronium ion is attracted to the high electron density of the polymeric bond’s oxygen atom, forming 
the transition state complex. Third, the reaction generates a ternary complex among 
glucosamine(ethylene glycol), the glucosamine(ethylene glycol) cation, and water. Finally, these three 
product molecules separate. The relative energy of each step in the acid hydrolysis of 
diglucosamine(ethylene glycol) was calculated (Figure 3). 
 
Figure 3. Relative energies of reaction intermediates during the acid hydrolysis of 
diglucosamine(ethylene glycol) calculated with B3LYP/6-31G//PM3. The reaction 
mechanism involves the four steps listed below. 
I. Diglucosamine(ethylene glycol) is attracted by hydronium ion.  
II. Diglucosamine(ethylene glycol) and the hydronium ion form a binary complex.  
III. The ternary product complex is generated containing glucosamine(ethylene glycol), a glucosamine 
(ethylene glycol) cation, and water. 
IV. The products dissociate into their final, stable states. 
 
The acid hydrolysis reaction was simulated using B3LYP/6-31G//PM3 level calculations. The 
probability of reaction is related to the relative energy of the reaction. If the net change in energy for 
the reaction is negative, then product formation is favored. If the relative energy change is more 
negative, then the reaction products are more highly favored. The energies of each step were calculated Int. J. Mol. Sci. 2008, 9  
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relative to the molecular energy of step I, which represents the reactants. The energy of the transition 
state (step II) was 145.51 kcal/mol greater than that of the first step because the hydronium ion 
requires energy to react with glucosamine(ethylene glycol).  Two distinct structures can be considered 
as the reaction’s final products. The first structure (step III) was the ternary product complex of 
glucosamine(ethylene glycol), a glucosamine(ethylene glycol) cation, and water, and this complex was 
predicted to have energy of -92.61 kcal/mol relative to the reactants in step I. The second structure 
(step IV), in which none of the product molecules interact, had a relative energy of -7.29 kcal/mol. 
Thus, the simulation predicted that the product complex from step III would be formed because it was 
of lower energy and was more stable than the non-interacting of product structure from step IV.      
 
3.2.2. Neutral conditions 
 
It was again assumed that diglucosamine(ethylene glycol) was an acceptable reactant surrogate for a 
glucosamine(ethylene glycol) oligomer. Since the simulated solution was of neutral pH, H2O was used 
as the nucleophile.                  
 
Figure 4. Relative energies of reaction intermediates during the hydrolysis of 
diglucosamine(ethylene glycol) under pH neutral conditions calculated with B3LYP/6-
31G//PM3. The reaction mechanism involves four steps listed below. 
I. Diglucosamine(ethylene glycol) attracts the water molecule. 
II. Diglucosamine(ethylene glycol) and water form a binary complex. 
III. The binary product complex is generated containing two molecules of glucosamine(ethylene glycol). 
IV. The product complex dissociates into two molecules of glucosamine(ethylene glycol). Int. J. Mol. Sci. 2008, 9  
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The molecular energy of each step in the reaction mechanism was calculated relative to that of step 
I. The relative energy of the transition state was 135.78 kcal/mol. Both steps III and IV were 
considered for the final product. The first structure (stage III), which had a relative energy of -17.16 
kcal/mol, was the complex product containing two molecules of glucosamine(ethylene glycol). The 
second structure (stage IV), which had a relative energy of -19.93 kcal/mol, was the dissociated 
glucosamine(ethylene glycol) molecules (Figure 4). 
 
3.2.3. Basic conditions 
 
Again, diglucosamine(ethylene glycol) was assumed to be an acceptable reactant surrogate for a 
glucosamine(ethylene glycol) oligomer. As hydrolysis was simulated under basic conditions, OH
- was 
used as the nucleophile.  
Two different hydrolysis products can form under basic conditions. Either the hydroxide ion reacts 
with the polymeric bond forming the desired products or it deprotonates the molecule. In the case of 
the former reaction, the high electron density on the oxygen of the polymer bond repels the hydroxide 
ion, hindering nucleophilic attack. In the case of the latter reaction, the hydroxide ion removes a proton 
from the ethylene glycol moiety of diglucosamine(ethylene glycol) forming a dimeric anion.  
 
3.2.3.1. Hydroxide ion hydrolysis of the polymeric bond  
 
Under basic conditions, a hydroxide ion can act as a nucleophile to hydrolyze the 
diglucosamine(ethylene glycol) polymeric bond. The relative energy of the transition state was 287.60 
kcal/mol. Both steps III and IV were considered for the final product. The first structure, which had a 
relative energy of -108.43 kcal/mol, was the binary product complex containing two molecules of 
glucosamine(ethylene glycol). The second structure, which had a relative energy of -89.33 kcal/mol, 
was dissociated complex consisting of a molecule of glucosamine(ethylene glycol) and 
glucosamine(ethylene glycol) anion (Figure 5).  
The high activation energy of this reaction suggested that this reaction cannot proceed at an 
appreciable rate. The high relative energy of the transition state was attributed to the repulsive effect of 
the high electron density on the polymeric linkage. 
 
3.2.3.2. Hydroxide ion deprotonates ethylene glycol group  
 
 The hydroxide can also deprotonate the ethylene glycol moiety of diglucosamine(ethylene glycol) 
under base conditions and the relative energy of each mechanistic step was calculated (Figure 6).  
The relative energy of the transition state was -78.83 kcal/mol. This implied that this reaction would 
dominate under basic conditions because it was much faster than hydrolysis. Two possible products 
were considered to follow the transition state. The first structure, which had an energy of -82.64 
kcal/mol, was the product complex containing a diglucosamine(ethylene glycol) anion and a molecule 
of water. The second structure, which had an energy of -62.01 kcal/mol, was the dissociated 
diglucosamine(ethylene glycol) molecule. Int. J. Mol. Sci. 2008, 9  
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Figure 5. Relative energies of reaction intermediates during the basic hydrolysis of 
diglucosamine(ethylene glycol) calculated with B3LYP/6-31G//PM3. The reaction 
mechanism involves the four steps listed below. 
I. Diglucosamine(ethylene glycol) attracts the hydroxide ion. 
II. Diglucosamine(ethylene glycol) forms a complex with the hydroxide ion. 
III. The binary product complex is generated containing glucosamine(ethylene glycol) anion and a 
glucosamine(ethylene glycol). 
IV. The binary complex dissociates into one molecule of glucosamine(ethylene glycol) anion and a 
glucosamine(ethylene glycol). 
 
The results for all three conditions (acid, neutral, and basic) are summarized in Table 3. The 
activation energy was highest for the basic hydrolysis reaction (Basic I). With the exception of neutral 
hydrolysis conditions, the product complex states (all mechanisms, step III) had relative energies lower 
than those of the dissociated products (all mechanisms, step IV). This implied that the molecules most 
likely stay closely associated following reaction. From these stages (step III), the complex molecules 
can move apart from each other and stay in stable form with optimum structure (stage IV). In the case 
of a competing side reaction under basic conditions (basic II), the high electron density at the ethylene 
glycol oxygen is insufficient to repel the hydroxide anion and prevent deprotonation but at hydrogen is 
mild electron density, which occurs very rapidly. The hydroxide anion is likely to form at hydrogen 
position of ethylene glycol than of polymer bond. 
These predictions agreed with the experimental results of Oungbho et al. [18], who found that drug 
release from chitosan was much more favorable under acidic conditions than under neutral conditions. 
Under basic conditions, the hydroxide ion is difficult to attack at polymer bond because of very high Int. J. Mol. Sci. 2008, 9  
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electron density but deprotonation of the ethylene glycol is much faster than hydrolysis, and so drugs 
cannot be released from a glucosamine(ethylene glycol) capsule in this manner. 
 
Figure 6. Relative energies of reaction intermediates during the deprotonation of 
diglucosamine(ethylene glycol) calculated with B3LYP/6-31G//PM3. The reaction 
mechanism involves the four steps listed below. 
I. Diglucosamine(ethylene glycol) attracts the hydroxide ion. 
II. Diglucosamine(ethylene glycol) forms a complex with the hydroxide ion. 
III. A binary product complex is generated containing a diglucosamine(ethylene glycol) anion and a 
molecule of water. 
IV. The product complex dissociates into a diglucosamine(ethylene glycol) anion a molecule of water. 
 
Table 3. Comparison of possible reaction pathways. 
Simulated Mechanism  Step I  Step II  Step III  Step IV 
 kcal/mol 
Acidic 0  145.50  -92.61  -7.29 
Neutral 0  135.78  -17.16  -19.93 
Basic I  0  287.6  -108.45 -89.33 
Basic II  0  -78.83  -82.64  -62.01 
 
3.3. Micelle formation 
 
Glucosamine(ethylene glycol) and doxorubicin can form complex micellar structures via hydrogen 
bonding. A molecule of glucosamine(ethylene glycol) consists of both hydrophobic (glucosamine) and Int. J. Mol. Sci. 2008, 9  
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hydrophilic (ethylene glycol) parts. The glucosamine moiety engages in hydrogen bonds with 
doxorubicin, while the ethylene glycol moiety allows the complex to dissolve in water.   
Micelle formation was simulated using B3LYP/6-31G//PM3 methods in which the partial charge 
distributions of doxorubicin and glucosamine(ethylene glycol) were considered. PM3 was used to 
optimize the structures of doxorubicin and glucosamine(ethylene glycol). As one can notice from 
figures, the red numbers and circles are H-bond between doxorubicin and glucosamine   
(ethylene glycol). 
 
Figure 7. Simulated doxorubicin micelle using B3LYP/6-31G//PM3 methods.  
 
 
(A) Micellar structure.  
where   n = 1; glucosamine-mono(ethylene glycol)  
            n = 2; glucosamine-di(ethylene glycol)  
            n = 3; glucosamine-tri(ethylene glycol)    
            n = 4; glucosamine-tetra(ethylene glycol)  
            n = 5; glucosamine-penta(ethylene glycol)  
(B) Molecular structure of glucosamine-penta(ethylene glycol) 
 
The charge structure of doxorubicin is obviously negative on O and N. Hydrogen bonds formed 
between the O-H and N-H groups of doxorubicin and glucosamine(ethylene glycol). In this simulation, 
the distribution of partial charges was calculated from electron density. The negative partial charges at 
the oxygen atoms of doxorubicin interacted with the positive partial charges of the protons of 
glucosamine(ethylene glycol). The charge consideration is calculated from high negative charge on O Int. J. Mol. Sci. 2008, 9  
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of doxorubicin and high positive charge on H of glucosamine(ethylene glycol) interaction. Predictions 
indicated that the doxorubicin structure contained three points of high electron density, and the 
glucosamine(ethylene glycol) possessed hydrogen atoms with low electron density. Micelle formation 
was hypothesized to require precisely controlled amounts of both the glucosamine and the ethylene 
glycol moieties. The stability of micelle is analyzed from the length of ethylene glycol chain and 
amount of glucosamine(ethylene glycol) to form micelle structure. The amount of ethylene glycol 
present was changed by the varying the length of the n-ethylene group in glucosamine(n-ethylene 
glycol) between n=1 and n=5. The simulated micelle is depicted in Figure 7. 
The energy of micelle formation was also related to the amount of glucosamine(ethylene glycol) 
present (Figure 8). Increasing the relative amount of ethylene glycol in glucosamine(n-ethylene glycol) 
presumably prevented water from becoming trapped within the hydrophobic part of the micelle and 
interfering with hydrogen bonding. This exclusion of water decreased the relative energy of micelle 
formation thereby facilitating the process. These simulations agreed with the results of Xiangjang [6] 
and  Mitra [9].  The relative energy of micelle formation also decreased when the number of 
glucosamine(ethylene glycol) molecules was increased because additional hydrogen bonding between 
doxorubicin and glucosamine-(ethylene glycol) provided additional stabilization. The amount of 
glucosamine(ethylene glycol) played a larger role in micelle stabilization than did the length of the n-
ethylene glycol side chain because more hydrogen bond makes micelle structure more stable. Once 
formed into a micelle, the ethylene glycol moiety shows the potential to be a doxorubicin delivery to 
cancer cells [5, 20-22]. 
 
Figure 8. Relationship between the relative energy of micelle formation and the amount of 
glucosamine(ethylene glycol) present. 
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4. Conclusions 
 
The hydrolytic release of doxorubicin from a glucosamine(ethylene glycol) oligomer capsule was 
simulated under acidic, neutral, and basic conditions. Using diglycosamine(ethylene glycol) as a 
surrogate substrate, hydrolysis was predicted under acidic and neutral conditions but not under basic 
conditions. Thus, an acidic environment, such as the stomach, may break the encapsulating polymer 
bonds. Deprotonation is favored over hydrolysis under basic conditions, so the capsule will not be 
broken in this case. 
Micelles formation from doxorubicin and glucosamine(n-ethylene glycol) depended on the length 
of the ethylene glycol side chain. According to B3LYP/6-31G//PM3 predictions, lengthening the 
ethylene glycol chain stabilized the resulting micelles, thereby facilitating their formation. The number 
of glucosamine(ethylene glycol) molecules included in the simulation was varied from one to three, 
and increasing the number of molecules also facilitated micelle formation. Thus, glucosamine(ethylene 
glycol) and doxorubicin will form complex micellar structures capable of acting as drug   
delivery systems. 
The capsule polymer used to deliver doxorubicin should possess a sufficiently long ethylene glycol 
chain to promote micelle formation. The length of the ethylene glycol chain also had an effect on 
polymer hydrolysis. In an acidic solution, increasing of the length of the ethylene glycol side chain 
facilitated hydrolysis because the side chain pulled H3O
+ from solution, thereby reducing the relative 
energy of the transition state. If, however, the ethylene glycol chain was too long, it reacted with the 
polymeric bond, forming (diglucosamine-tri(ethylene glycol)). In neutral and basic solutions, as the 
length of ethylene glycol chain increased, the polymeric bonds became more resistant to hydrolysis 
because the ethylene glycol side chain sterically hindered nucleophilic attack. 
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